According to the World Health Organization (WHO), breast cancer is among the most common cancers worldwide. Most of the anticancer agents have been showing a variety of side effects. Recently, bacterial proteins have been investigated as promising anticancer agents. Azurin is a bacterial cupredoxin protein secreted from Pseudomonas aeruginosa and has been reported as a potent multi-targeting anticancer agent, which makes it an appropriate candidate for drug delivery. Azurin may be delivered to cancer cells using different carriers like polymeric micro and nanoparticles. In the present study, azurin was extracted from the bacterial host and loaded into chitosan particles. Then its effect on MCF-7 cell line was investigated. Chitosan-azurin particles were made using the ion gelation method. Results showed that chitosan-azurin particles are about 200 nm, and the loading of the protein in particles did not affect its integrity. The MTT assay showed a significant reduction in cell viability in azurin and chitosan-azurin-treated cells. The toxicity level after 5 days was 63.78% and 82.53% for free azurin and chitosan-azurin-treated cells, respectively. It seems using an appropriate carrier system for anticancer proteins like azurin is a promising tool for developing low side effect anticancer agents.

Zero-valent iron is a moderately reducing reagent that is both non-toxic and affordable. In the present work, iron nanoparticles were synthesized using bitter guard leaf extract (Momordica charantia L.) (BGL-Fe NP). Using leaf samples from bitter protectant extract, iron nanoparticles were synthesized with secondary metabolites such as flavonoids and polyphenols acting as capping and reducing agents. Polyphenols reduce Fe²⁺/Fe³⁺ to nanovalent iron or iron nanoparticles. Iron nanoparticles were synthesized by reducing iron chloride as a precursor with bitter protective leaf extract in an alkaline environment. The obtained BGL-Fe NPs were calcined for 4 h at various temperatures of 400 °C, 500 °C, and 600 °C. The obtained samples were coded as BGL-Fe NPs-4, BGL-Fe NPs-5, and BGL-Fe NPs-6, respectively. The synthesized BGL-Fe NPs were systematically characterized by XRD, SEM, FTIR, UV-Vis and TG-DTA analysis. The obtained BGL-Fe NPs were then used as an adsorbent to remove the aqueous solution of basic methylene blue (MB) dye. MB concentration was monitored using UV-Vis spectroscopy.

Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. Cisplatin-loaded nanoparticle formulations were optimized utilizing response surface methods and the central composite rotating design model. This study employed a central composite rotatable design with a three-factored factorial design with three tiers. Three independent variables namely drug polymer ratio, aqueous organic phase ration, and stabilizer concentration were used to examine the particle size, entrapment efficiency, and drug loading of cisplatin PLGA nanoparticles as responses. The results revealed that this response surface approach might be able to be used to find the best formulation for the cisplatin PLGA nanoparticles. A polymer ratio of 1:8.27, organic phase ratio of 1:6, and stabilizer concentration of 0.15 were found to be optimum for cisplatin PLGA nanoparticles. Nanoparticles made under the optimal conditions found yielded a 112 nm particle size and a 95.4 percent entrapment efficiency, as well as a drug loading of 9 percent. The cisplatin PLGA nanoparticles tailored for scanning electon microscopy displayed a spherical form. A series of in vitro tests showed that the nanoparticle delivered cisplatin progressively over time. According to this work, the Response Surface Methodology (RSM) employing the central composite rotatable design may be successfully used to simulate cisplatin-PLGA nanoparticles.

This work presents the evaluation of iron oxide nanoparticles obtained from the aqueous extract of Eucalyptus grandis. Twenty-three experiments were carried out where the synthesis of nanoparticles was performed by using the aqueous extract together with salts of iron (II) chloride tetrahydrate and iron (III) chloride hexahydrate. A characterization was carried out by IR, TEM and BET, where bands were presented at 3,440.77, 1,559.26 and 445.31 cm⁻¹, indicating the presence of iron oxide nanoparticles. A relatively high monodispersity was evidenced with particles around 9 nm. By means of BET analysis it was found to present a surface area of 131.897 m²/g. Obtaining nanoparticles by this green method presents yield values of 98%, with application in nanotechnology, biomedicine, environmental treatment, among others, making them highly versatile and their production cost is relatively low.

Broad-spectrum antibiotics, such as tetracyclines, are used to treat and manage a range of infectious disorders. Since the kidneys are the primary organs responsible for excreting tetracyclines, clinicians should refrain from prescribing them to patients who have renal failure. Tetracyclines are one of the clinical waste products of today. One of the biggest problems in the field of pollution of the environment today is the persistence of different pharmaceutical residues, drug residues, pesticides, and metal ion species of the new-generation pollutants in surfaces and groundwater. In the present work, carboxymethyl cellulose (CMC)-CuO nanoparticles (CMC-CuO NPs) were synthesized using CuO NPs within different amounts of CMC (0.5, 1.0, 1.5 and 2.0 g) at 85 °C. The synthesized nanoparticles were characterized by XRD, FT IR, SEM, and TG-DTA analysis. According to XRD and SEM, the crystallize size and morphology influenced the dosage of CMC. FT-IR analysis confines the layer of CMC to the CuO nanoparticle surface. TG-DTA results indicated that the CMC content of CMC-CuO NPs was between the range of 69% and 75% by weight. The effects of some parameters such as initial concentration, pH, adsorbent dosage, and contact time on the adsorption of tetracycline from aqueous model solutions on CMC-CuO NPs were investigated with batch studies. It was found that the removal of tetracycline was obtained about 80% with optimized parameters of 10 mg/L concentration, 180 min contact time, 5 pH, and 0.3 g/25 mL dose. The synthesized CMC-CuO NPs nanocomposite may be a promising material for the removal of tetracycline in environmental pollution and toxicology.